Infectious Diseases Flashcards

1
Q

antibiotics for AOM

A

< 24 yo

  • poor risk of f/u
  • chronic illneses
  • recurrent, severe, perforate dAoM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

treatment of AOM?

A

amoxicillin = 1st line
-if no improvement w/in 48 hrs
(2nd line = amox-clavulanic, oral 2nd/3rd gen cephalosporin, IM ceftriaxone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

complication of AOM?

A

otitis media with effusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

when to place ear tubes?

A

OME persisting more than 3 weeks

  • +4 episodes of AOM w/in 6 mo
  • 5 episodes w/in 12 mo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

copmlications of AOM?

A

excessive scarring / tympanosclerosis
cholestatoma formation
chronic suppurative AOM
rarely: mastoiditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

presentation of acute bacterial sinusitis

A

1) persistent respiratory symptoms > 10-14 days w/o improvement + nasal d/c (clear/purulent) & daytime cough
2) severe symptoms of high fever / purulent nasal d/c for > 3 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

complications of acute bacterial sinusitis

A

-bony erosion, orbital cellulitis, intracrnial extension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are complications of group A strep?

A
  • suppurative (peritonsillar / retropharyngeal abscess)

- nonsuppurative (rheumatic fever, post-strep glomerulonephritis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

treatment of group A strep

A

10-day course of oral penicillin / single-dose IM benzathine penicillin G

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

treatment of scarlet fever

A

same as GAS pharyngitis

-10 day oral penicillin / single-dose Im benzathine penicillin G

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GAS treatment for penicillin allergy

A

erythromycin, azithromycin, clindamycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

diagnostic criteria for acute rheumatic fever/

A

JONES criteria
Major: carditis, polyarthritis, chorea, erythema marginatum, subQ nodules
Minor: fever, arthralgia, elevated ESR/CRP, prolonged PR interval
Other: +throat culture/rapid antigen test / incr. ASO titers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

EBV + misdiagnosis & amoxi/amp?

A

skin rash = maculopapular, on face/trunk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

eval of EBV?

A

leukocytosis

  • lymphocytes >50% of leukocytes
  • heterophile antibody test = rapid EBV detection
  • no detectable heterophile antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

croup presentation?

A

upper airway obstruction - hoarse voice/barky-seal-like cough + inspiratory stridor –> respiratory distress

  • laryngotracheal inflammation
  • parainfluenza virus, influenza, RSV
  • more pronounced in 6-36 mo (narrow airway)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

croup treatment

A

1) cool air / humidity
2) expect resolution w/in 4-7 days
3) nebulized racemic EPI; oral/IV/IM corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

bronchiolitis

A
  • acute viral lower respiratory tract infection –> obstruction of peripheral airways
  • lymphocytic infiltrate into peribronchial/peribronchiolar epithelium –> submucosal edema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

bronchiolitis pathogen

A

typically RSV

  • nov-april
  • > 50% younger than 1 yo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

clinical bronchiolitis signs

A
  • neonates - at risk for apnea

- resolve w/in 5-10 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

CXR consistent w/ RSV

A
  • lung hyperinflation
  • peribronchial thickening/cuffing
  • incr. interstitial markings
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

indications for palivizumab?

A

prophylaxis for pts > 2 yo

risk for severe disease (premature infants / children w/ bronchopulm dysplasia, req . O2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is palivizumab?

A

IM RSV monoclonal antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is respigam?

A

IV polyclonal immunoglobulin + high RSV antibody concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

pertussis presentation

A

afebrile, prolonged cough (2-8 wks)

  • catarrhal phase - follows 7-10 day incubation (1-2 wks of low grade fever, cough, coryza)
  • paroxysmal phase - intense coughin spasms + sudden inhalation
  • convalescent phase
25
pertussis eval
-detected by fluorescent antibody staining, PCR, culture
26
treatment of pertussis
- hospitalization of young infants w/ severe disease | - erythromycin / macrolides - shorten duration of illness, if given in catarrhal phase & dec. infectivity
27
what are causes of PNA in children?
- viruses = most common - chlamydia trachomatis - 2-3 mo - s. pneumo = community-acquired
28
school aged PNA
- mycoplasma pneumo / chlamydia pneumonai | - not common if < 5 yo
29
unusually causes of PNA?
nontypeable H. flu, m. catarrhalis, S. aureus, N. meningitidis, GAS
30
risk factors for bacterial PNA
chronic lung disease (CF/asthma) neuro impairment (swallowing dysfunction / NMJ disease) GERD w/ aspiration Upper airway anatomic defects (tracheoesphageal fistula/cleft palate) Hemoglobinopathy (sickle cell) Immunodeficiency/immunosuppresion
31
most common signs of PNA in id?
tachypnea / dyspnea out of proprtion to fever
32
pulm exam findings of viral/atypical PNA
- diffuse wheezing / crackles = multiple areas involved | (m. pneumo, c. pneumo, c. trachomatis)
33
pulm exam findings of bacterial PNA
focal crackles / dec. breath sounds dullness to percussion egophony bronchophony
34
outpt treatment of bacterial PNA
amoxicillin or amoxi-clavulanic acid
35
walking PNA
m. /c pneumo | - treat w/ macrolides 9erythromycin, clarithromycin, azithromycin)
36
IV a/b for PNA
ampi-sulbactam clindamycin cefuroxime, ceftriaxone, azithromycin, vanco
37
causes of mengingitis < 1 mo
GBS, e. coli, gram neg bacili, HSV, listeria, strep pneumo
38
meningitis 1-2 mo
e. coli s. pneumo enteroviruses h. influenza GBS
39
2mo - 6 yr - meningitis
``` strep pneumo n. meningitidis enteroviruses borrelia burgdorferi h. influ type b ```
40
school age/adolescent meningitis
s. pneumo n. meningitidis enteroviruses b. burgdoreferi
41
features of lyme meningitis
low grade fever, headache, stiffneck, photophobia | ?cranial nerve palsies
42
signs of meningitis on PE
kernig (flexion of leg at the hip + subsequent pain on knee extension) brudzinski (involuntary leg flexion on passive neck flexion)
43
CSF findings for bacterial meningitis
WBC > 1000 neutrophils > 75% protein: incr.!! glucose (down)
44
CSF findings for viral meningitis?
WBC < 500 lymphocytosis protein: nL glucose: nL
45
CSF findings for lyme meningitis
WBC < 100 neutrophils: < 30% protein nL/incr. glucose: nL
46
IV a/b for meningitis - infants / adolescents?
vanco + 3rd gen cephalosporin (cefotaxime / ceftriaxone) | 10-14 days
47
neonate meningitis treatment
amp - GBS / Listeria cefotaxime - gram - pathogens 14-21 days
48
special considerations for meningitis treatment
5-7 days for meningococcal meningitis | -lyme - 14-28 days
49
most common causes of bacterial GI
salmonella, shigella, e. coli,yersinia enterocolitica, campylobacter jejuni, v. cholera
50
signs of bacterial diarhea
fever, abdominal cramping, malaise, tenesmus | stools w/ mucus + blood
51
complications of salmonella bactermia
osteomyelitis / meningitis
52
erythema nodosum
``` yersinia enterocolitca infxn - 30% speudoappendicitis picture (localizes to RLQ) ```
53
when to use a/b for salmonella diarrhea?
a/b prolongs salmonella shedding | reserve for bactermia / extraintestinal dissemnation for (< 3 mo / immunocompromise) w/ noninvasive gastroenteritis
54
treatment of shigellosis
TMP-SFX
55
C. jejuni treatment
erythromycin
56
treatment of epiglotttis + presentation
toxic appearance + drooling severe, progressive respiratory distress -endotracheal intubation + direct visualization
57
transmission of HAV/HEV?
fecal oral
58
transmission of HB/C/DV
bodily fluids